PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS

Bibliographic Details
Main Authors:	Mohamed Rayen Ganouni, Malek Jemni, Yassine Khalij, Bissene Douma, Sana Boujaafer, Dorra Amor, Salma Naija, Asma Asma, Sana Amor, Ali Bouslama
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123020055

Similar Items

Beta-interferons in multiple sclerosis
by: Aggarwal Sourabh, et al.
Published: (2010-01-01)

Interferon beta treatment of multiple sclerosis.
by: Markovitz, D
Published: (1994)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
by: Sibley, W, et al.
Published: (1994)

Treatment of multiple sclerosis with interferon beta-1 b.
by: Abdul-Ahad, A, et al.
Published: (1997)

Capillarys 3 Octa®: Analytical Performance Assessment for HbA1c Quantification
by: Ganouni Mohamed Rayen, et al.
Published: (2022-05-01)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
by: Sørensen, P, et al.
Published: (2010)

Treatment of multiple sclerosis with interferon beta-1b - Reply
by: Sibley, W, et al.
Published: (1997)

Interferon-beta injection site reactions in patients with multiple sclerosis
by: Martina Maurelli, et al.
Published: (2018-11-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01)

A cost-utility analysis of interferon beta for multiple sclerosis.
by: Parkin, et al.
Published: (1998-01-01)

THE INFLUENCE OF NEUTRALIZING ANTIBODIES TO INTERFERON-BETA ON PROGRESSION OF MULTIPLE SCLEROSIS
by: V. Yu. Lizhdvoy, et al.
Published: (2016-07-01)

Flagellate dermatitis: An atypical skin finding in adult‐onset Still's disease
by: Sana Toujani, et al.
Published: (2022-10-01)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01)

Beta-interferons in multiple sclerosis: A single center experience in India
by: Gupta Salil, et al.
Published: (2010-01-01)

Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
by: Ivanović Jovana, et al.
Published: (2019-01-01)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
by: De Caro Maria, et al.
Published: (2006-12-01)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
by: Cocco E, et al.
Published: (2015-05-01)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
by: Castrop F, et al.
Published: (2013-09-01)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
by: Elmazny A, et al.
Published: (2020-03-01)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
by: Lampasona, V, et al.
Published: (2003)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
by: Alexandre Xavier, et al.
Published: (2023-05-01)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
by: Naeim Ehtesham, et al.
Published: (2016-11-01)

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
by: Miraç Ayşen Ünsal
Published: (2019-03-01)

Erratum to Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE
Published: (2015-01-01)

Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
by: Amir Hadi Maghzi, et al.
Published: (2012-02-01)

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
by: Keivan Basiri, et al.
Published: (2012-02-01)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
by: Reuss R
Published: (2013-05-01)

Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy
by: C. Carbonelli, et al.
Published: (2015-12-01)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Damiano Paolicelli, et al.
Published: (2009-07-01)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is there an odd one Out?
by: Alexis Clapin
Published: (2012-04-01)

Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis
by: Marco Aurélio Lana-Peixoto, et al.
Published: (2002-09-01)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)

Pharmacogenetics in multiple sclerosis: the long and winding road ahead of us
by: Yara Dadalti Fragoso

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
by: Parry, A, et al.
Published: (2003)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
by: Parry, A, et al.
Published: (2002)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01)

THE EFFECTIVENESS OF INTERFERON BETA-1A IN MANAGEMENT OF MULTIPLE SCLEROSIS: A CASE REPORT
by: Journal, Malang
Published: (2020-07-01)

Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
by: V. Byrnes, et al.
Published: (2006-01-01)

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
by: Mahe J, et al.
Published: (2013-08-01)